These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25642981)

  • 1. Is Notch Signaling a Specific Target in Hepatocellular Carcinoma?
    Sun L; Sun G; Yu Y; Coy DH
    Anticancer Agents Med Chem; 2015; 15(7):809-15. PubMed ID: 25642981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.
    Han P; Li H; Jiang X; Zhai B; Tan G; Zhao D; Qiao H; Liu B; Jiang H; Sun X
    Mol Oncol; 2017 Mar; 11(3):320-334. PubMed ID: 28164434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer treatments for advanced hepatocellular carcinoma.
    Song MJ; Bae SH
    Korean J Intern Med; 2014 Mar; 29(2):149-55. PubMed ID: 24648795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of signaling pathways involved in sorafenib resistance of hepatocellular carcinoma.
    Makarova AS; Lazarevich NL
    Klin Lab Diagn; 2013 Oct; (10):66-8, 34-7. PubMed ID: 24640100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?
    Sacco R; Antonucci M; Bargellini I; Marceglia S; Mismas V; Cabibbo G
    Future Oncol; 2015; 11(17):2371-3. PubMed ID: 26270206
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeted Therapy for Hepatocellular Carcinoma.
    Ohri N; Kaubisch A; Garg M; Guha C
    Semin Radiat Oncol; 2016 Oct; 26(4):338-43. PubMed ID: 27619254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance.
    Dietrich P; Koch A; Fritz V; Hartmann A; Bosserhoff AK; Hellerbrand C
    Gut; 2018 Jul; 67(7):1328-1341. PubMed ID: 29275358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic therapy of hepatocellular carcinoma: current and promising.
    Kalyan A; Nimeiri H; Kulik L
    Clin Liver Dis; 2015 May; 19(2):421-32. PubMed ID: 25921671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma.
    Yoo SY; Badrinath N; Woo HY; Heo J
    Mediators Inflamm; 2017; 2017():5198798. PubMed ID: 28512387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways and targets in hepatocellular carcinoma.
    Psyrri A; Arkadopoulos N; Vassilakopoulou M; Smyrniotis V; Dimitriadis G
    Expert Rev Anticancer Ther; 2012 Oct; 12(10):1347-57. PubMed ID: 23176622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy.
    Hung MH; Tai WT; Shiau CW; Chen KF
    World J Gastroenterol; 2014 Nov; 20(41):15269-74. PubMed ID: 25386075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization and sorafenib in hepatocellular carcinoma.
    Cabibbo G; Tremosini S; Galati G; Mazza G; Gadaleta-Caldarola G; Lombardi G; Antonucci M; Sacco R
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):831-45. PubMed ID: 24850249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma.
    Chen J; Jin R; Zhao J; Liu J; Ying H; Yan H; Zhou S; Liang Y; Huang D; Liang X; Yu H; Lin H; Cai X
    Cancer Lett; 2015 Oct; 367(1):1-11. PubMed ID: 26170167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.
    Gandhi M; Choo SP; Thng CH; Tan SB; Low AS; Cheow PC; Goh AS; Tay KH; Lo RH; Goh BK; Wong JS; Ng DC; Soo KC; Liew WM; Chow PK;
    BMC Cancer; 2016 Nov; 16(1):856. PubMed ID: 27821083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma.
    Sun T; Liu H; Ming L
    Cell Physiol Biochem; 2017; 44(2):716-727. PubMed ID: 29169150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of continuous administration of sorafenib in combination with modified transarterial chemoembolization in patients with unresectable hepatocellular carcinoma.
    Huang YH; Chen W; Li JP; Chen B; Yang JY
    Chin Med J (Engl); 2013 Jan; 126(2):385-6. PubMed ID: 23324295
    [No Abstract]   [Full Text] [Related]  

  • 18. Upregulated expression of Nucleostemin/GNL3 is associated with poor prognosis and Sorafenib Resistance in Hepatocellular Carcinoma.
    Hua L; Hu B; Yan D; Liu J; Shen Y; Zhao F; Shen C; Chen B; Cui X
    Pathol Res Pract; 2017 Jun; 213(6):688-697. PubMed ID: 28476378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Remission of Unresectable Hepatocellular Carcinoma After Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization.
    Lorenzin D; Pravisani R; Leo CA; Bugiantella W; Soardo G; Carnelutti A; Umberto B; Risaliti A
    Cancer Biother Radiopharm; 2016 Mar; 31(2):65-9. PubMed ID: 26986817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic strategy for hepatocellular carcinoma by molecular targeting agents via inhibition of cellular stress defense mechanisms.
    Honma Y; Harada M
    J UOEH; 2014 Dec; 36(4):229-35. PubMed ID: 25501753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.